Jamjoom Pharmaceuticals Factory Logo

Jamjoom Pharmaceuticals Factory (4015)

Tadawul

Currency in SAR
138.90
-2.10 (-1.49%)

Closed

Aug 27, 2026

Day's Range

138.90
142.40

52 wk Range

125.00
165.30

Overview - 4015 - Jamjoom Pharmaceuticals Factory

Key Statistics

Valuation

Enterprise Value

9.62B

P/E (Trailing)

‪20.52‬

P/E (Forward)

‪17.94‬

PEG Ratio

‪-1.70‬

Price / Sales (TTM)

‪6.27‬

Price / Book

‪5.25‬

EV / EBITDA

‪17.67‬

Profitability

Gross Margin

‪65.94%‬

Profit Margin

‪30.54%‬

Operating Margin

‪32.78%‬

Return on Assets

‪14.13%‬

Return on Equity

‪26.99%‬

Ownership

Shares Outstanding

70.00M

Float

24.01M

Held by Insiders

‪61.38%‬

Held by Institutions

‪3.30%‬

Price stats

Beta

‪0.33‬

50-Day Avg

‪146.87‬

200-Day Avg

‪145.97‬

Dividends

Payout Ratio

‪58.22%‬

Frequency

Semi-Annual

Analyst Consensus

Hold

4 analysts

News Teaser - 4015 - Jamjoom Pharmaceuticals Factory

News & Analysis

View all news

Market Cap - 4015 - Jamjoom Pharmaceuticals Factory

Peers - 4015 - Jamjoom Pharmaceuticals Factory

Profile Summary - 4015 - Jamjoom Pharmaceuticals Factory

About

Jamjoom Pharmaceuticals Factory is a prominent player in the pharmaceutical industry based in Saudi Arabia. As a manufacturer, the company's primary function is to develop, produce, and distribute a broad range of pharmaceutical products. Jamjoom Pharmaceuticals serves multiple sectors, including healthcare,…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.